These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 27965143)

  • 1. Anticholinergic activity in the nervous system: Consequences for visuomotor function.
    Naicker P; Anoopkumar-Dukie S; Grant GD; Kavanagh JJ
    Physiol Behav; 2017 Mar; 170():6-11. PubMed ID: 27965143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medications influencing central cholinergic pathways affect fixation stability, saccadic response time and associated eye movement dynamics during a temporally-cued visual reaction time task.
    Naicker P; Anoopkumar-Dukie S; Grant GD; Modenese L; Kavanagh JJ
    Psychopharmacology (Berl); 2017 Feb; 234(4):671-680. PubMed ID: 27988806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medications influencing central cholinergic neurotransmission affect saccadic and smooth pursuit eye movements in healthy young adults.
    Naicker P; Anoopkumar-Dukie S; Grant GD; Kavanagh JJ
    Psychopharmacology (Berl); 2017 Jan; 234(1):63-71. PubMed ID: 27671681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central cholinergic pathway involvement in the regulation of pupil diameter, blink rate and cognitive function.
    Naicker P; Anoopkumar-Dukie S; Grant GD; Neumann DL; Kavanagh JJ
    Neuroscience; 2016 Oct; 334():180-190. PubMed ID: 27531858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive function.
    Ogino S; Miyamoto S; Miyake N; Yamaguchi N
    Psychiatry Clin Neurosci; 2014 Jan; 68(1):37-49. PubMed ID: 24102938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The adverse effects of anticholinergic drugs].
    Iwaki H; Nomoto M
    Brain Nerve; 2014 May; 66(5):551-60. PubMed ID: 24807371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of procyclidine on eye movements in schizophrenia.
    Ettinger U; Kumari V; Zachariah E; Galea A; Crawford TJ; Corr PJ; Taylor D; Das M; Sharma T
    Neuropsychopharmacology; 2003 Dec; 28(12):2199-208. PubMed ID: 12942142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinergics: theoretical and clinical overview.
    Nishtala PS; Salahudeen MS; Hilmer SN
    Expert Opin Drug Saf; 2016 Jun; 15(6):753-68. PubMed ID: 26966981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cholinergic mechanism for eye fixation.
    Navarro-López Jde D; Yajeya J; Delgado-García JM
    J Mol Neurosci; 2006; 30(1-2):125-8. PubMed ID: 17192657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model.
    Yoshiyama Y; Kojima A; Itoh K; Uchiyama T; Arai K
    Neurobiol Dis; 2012 Jan; 45(1):329-36. PubMed ID: 21889983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling.
    Kistemaker LE; Gosens R
    Trends Pharmacol Sci; 2015 Mar; 36(3):164-71. PubMed ID: 25511176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergics in palliative medicine: an update.
    Prommer E
    Am J Hosp Palliat Care; 2013 Aug; 30(5):490-8. PubMed ID: 22964342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholine and delirium.
    Tune LE; Egeli S
    Dement Geriatr Cogn Disord; 1999; 10(5):342-4. PubMed ID: 10473936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response curves and time-course effects of selected anticholinergics on locomotor activity in rats.
    Sipos ML; Burchnell V; Galbicka G
    Psychopharmacology (Berl); 1999 Dec; 147(3):250-6. PubMed ID: 10639682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomical and pharmacological relationship between acetylcholine and nitric oxide in the prepositus hypoglossi nucleus of the cat: functional implications for eye-movement control.
    Márquez-Ruiz J; Morcuende S; Navarro-López Jde D; Escudero M
    J Comp Neurol; 2007 Jul; 503(3):407-20. PubMed ID: 17503470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A constitutively active G protein-coupled acetylcholine receptor regulates motility of larval Schistosoma mansoni.
    MacDonald K; Kimber MJ; Day TA; Ribeiro P
    Mol Biochem Parasitol; 2015 Jul; 202(1):29-37. PubMed ID: 26365538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of anticholinergic effects of psychotropic drugs in humans.
    Penttilä J; Scheinin H; Syvälahti E
    Pharmacopsychiatry; 2005 Sep; 38(5):187-93. PubMed ID: 16189744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological motion influences the visuomotor transformation for smooth pursuit eye movements.
    Coppe S; de Xivry JJ; Missal M; Lefèvre P
    Vision Res; 2010 Dec; 50(24):2721-8. PubMed ID: 20800610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoisomers of N-substituted soft anticholinergics and their zwitterionic metabolite based on glycopyrrolate--syntheses and pharmacological evaluations.
    Wu WM; Wu J; Mori N; Buchwald P; Bodor N
    Pharmazie; 2008 Mar; 63(3):200-9. PubMed ID: 18444508
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.